Table 3.

Main results

After the treatment for HLPatients total N = 67
ABVD n = 37
Controls total N = 134
ABVD matched n = 74
P
Women having started a pregnancy    
ABVD group, n (%) 20 (54) 36 (48) .59 
In the entire cohort, n (%) 36 (53.7) 73 (54.5) .92 
Pregnancies    
ABVD group 32 67 .41 
In the entire cohort 58 136 .2 
Births    
ABVD group 26 52 .48 
In the entire cohort 48 104 .35 
Women wanting children who have had at least 1 birth in ABVD group 81% n.a.  
Median time to pregnancy (y), median (min-max) 4.8 (3.1-6.6) 6.8 (5-8.7) .21 
Difficulty getting pregnant, n (%) 9 (13) 25 (19) <.001 
Use of MAP, n (%) 7 (11) 7 (5) .125 
Age at the onset of menopause (y), median (min-max) 44.4 (36-55) 51.5 (36.2-59) .006 
After the treatment for HLPatients total N = 67
ABVD n = 37
Controls total N = 134
ABVD matched n = 74
P
Women having started a pregnancy    
ABVD group, n (%) 20 (54) 36 (48) .59 
In the entire cohort, n (%) 36 (53.7) 73 (54.5) .92 
Pregnancies    
ABVD group 32 67 .41 
In the entire cohort 58 136 .2 
Births    
ABVD group 26 52 .48 
In the entire cohort 48 104 .35 
Women wanting children who have had at least 1 birth in ABVD group 81% n.a.  
Median time to pregnancy (y), median (min-max) 4.8 (3.1-6.6) 6.8 (5-8.7) .21 
Difficulty getting pregnant, n (%) 9 (13) 25 (19) <.001 
Use of MAP, n (%) 7 (11) 7 (5) .125 
Age at the onset of menopause (y), median (min-max) 44.4 (36-55) 51.5 (36.2-59) .006 
Close Modal

or Create an Account

Close Modal
Close Modal